For more than 20 years, women entering menopause have been warned that hormone-replacement therapy (HRT) carries major risks. The black-box warning placed on estrogen products after early WHI findings shaped an entire generation’s beliefs about menopause care — often leading women to suffer through symptoms unnecessarily.
Now, the FDA has officially removed that broad black-box warning.
This decision marks a turning point in women’s health and has meaningful implications for patients seeking primary care in New Milford.
At Active Health, our Chief Medical Officer Dr. Nicole Altorelli — along with fellow physicians Dr. Abra Mabasa and Dr. Jon Lis — welcomes this change. Their collective position is straightforward: for many women, modern hormone therapy is safer, more effective, and more individualized than past messaging led them to believe.
Why the FDA Made This Change
The old warning treated all hormone therapies and all patients the same, regardless of age, timing, formulation, or delivery method. Today’s research paints a more accurate picture.
A 2025 analysis in JAMA Internal Medicine showed:
- Women 50–59 using estrogen-based HRT did not experience increased cardiovascular disease risk.
- Risks were mainly seen when therapy was initiated in women around age 70.
- This supports the “window of opportunity” — HRT is safer and more effective when started earlier in menopause.
- Modern formulations (bioidentical estradiol, patches, localized vaginal estrogen) have improved safety profiles.
The FDA’s decision aligns the labeling with current evidence, rather than outdated fear.
Active Health’s Medical Perspective
Dr. Nicole Altorelli, our Chief Medical Officer and a trusted provider of primary care in New Milford, explains:
“I’m very excited that more women will have more access and less fear surrounding these therapies. Vaginal estrogen is extremely safe and can improve urogenital symptoms and reduce UTIs. More evidence shows significant benefits when HRT is used early in menopause. We now have excellent FDA-approved bioidentical options with better safety profiles than what was studied in the early 2000s.”
Both Dr. Abra Mabasa and Dr. Jon Lis, physicians at Active Health, share this view and emphasize that women deserve access to individualized, evidence-based menopause care—not blanket warnings that no longer reflect current science.
Their agreement reinforces that the FDA’s update supports what many modern clinicians already practice: thoughtful, case-by-case decision-making.
Dispelling the Biggest Myths About Estrogen Therapy
1. “Estrogen therapy is dangerous for everyone.”
The risk depends on age and timing, not simply the presence of estrogen.
For many women in their 40s, 50s, and early 60s, the benefits often outweigh the risks.
2. “All hormone therapies are the same.”
Not at all. Options now include:
- bioidentical estradiol
- transdermal patches
- localized vaginal estrogen (very low systemic absorption)
- safer progesterone pairings when needed
Today’s therapies look nothing like the one-size-fits-all formulations of the early WHI era.
3. “HRT is only for hot flashes.”
Women may experience improvements in:
- sleep quality
- cognitive clarity
- sexual health
- urinary frequency
- recurring UTIs
- bone health
- joint comfort
- overall quality of life
This is about function, not just symptom suppression.
How This Fits Into Active Health’s Integrative Approach
As a preventive-care practice, Active Health combines:
- Strength & Joint-Safe Movement – Declining estrogen affects muscle, connective tissue, and recovery. Our personal training and mobility coaching help women maintain strength and remain active through menopause.
- Nutrition & Metabolic Support – Menopause shifts metabolism, insulin sensitivity, and fat distribution. Our health coaching helps women adapt without resorting to fad diets or quick fixes.
- Evidence-Based Medical Care – With updated FDA guidance, our primary care team can provide more individualized recommendations for HRT, ensuring each woman’s plan fits her symptoms, health history, and long-term goals.
This combined model is what differentiates Active Health from traditional primary care.
Who Should Consider Talking to a Physician About HRT?
You may benefit from a conversation with our clinical team if you’re:
- within 10 years of menopause
- dealing with hot flashes or night sweats
- experiencing vaginal dryness or frequent UTIs
- noticing new joint stiffness or slower recovery
- struggling with fatigue, sleep issues, or brain fog
- seeing unexpected weight or body composition changes
- wanting to protect long-term bone and heart health
And virtually all post-menopausal women, in particular those over 65, can safely use vaginal estrogen. This remains one of the safest and most effective therapies available to improve vaginal dryness and significantly reduce risk of UTIs, regardless of sexual activity
Moving Forward: What This Means for Women
The FDA’s decision does not mean every woman needs hormone therapy — but it finally removes fear that was never evidence-based for most patients.
Women deserve:
- individualized care
- modern evidence
- symptom relief
- improved quality of life
- transparency from their healthcare team
At Active Health, that’s exactly what our physicians — Dr. Altorelli, Dr. Mabasa, and Dr. Lis — are committed to delivering.
If You Want to Explore HRT or Better Navigate Menopause, We’re Here to Help
Our primary care team at Active Health can help you understand your options, evaluate your symptoms, and build a treatment plan that considers:
- hormones
- strength training
- mobility
- nutrition
- metabolic health
- long-term wellbeing
You don’t need to navigate menopause alone — and you certainly don’t need to suffer through it.
Interested in learning more about Active Health? Check out our website and learn more about becoming a patient here.
– Medically reviewed by Dr. Nicole Altorelli, Chief Medical Officer at Active Health.
